[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RedChip
RedChip has been hosting investor webinars with various companies, including Calidi Biotherapeutics, Bullfrog AI, and Processa Pharmaceuticals. These webinars provide insights into the companies' innovative approaches to cancer treatment, AI-guided drug development, and other healthcare advancements. RedChip is also highlighting companies like ASP Isotopes, which is pioneering the next frontier of isotope production.
About RedChip
RedChip is a financial media and investor relations firm that provides research, analysis, and investor relations services to small and micro-cap companies.
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1-Year High: XXXXX on 2025-07-24
1-Year Low: XXX on 2025-07-26
| Social Network | X | YouTube | |
|---|---|---|---|
| Engagements | XXXXX | XXXXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-07-25
1-Year Low: XX on 2025-07-26
| Social Network | X | YouTube | |
|---|---|---|---|
| Mentions | XX | XX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning RedChip in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: X
1-Year High: XX on 2025-07-25
1-Year Low: X on 2025-07-26
The most influential creators that mention RedChip in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @RedChip | X | XXXXX | X | XXXXX |
| @redchip | X | XXXXXX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1-Year High: XXX% on 2025-07-24
1-Year Low: XXX% on 2025-07-24
Most Supportive Themes
- Investor Webinars and CEO Interviews: (60%) RedChip is actively promoting investor webinars and CEO interviews for various companies, highlighting their innovative approaches and potential for growth.
- Healthcare and Biotech Advancements: (30%) The community is buzzing about the potential of companies in the healthcare and biotech sectors, with a focus on advancements in cancer treatment, diagnostics, and mental health.
- Tech-Driven Innovation: (10%) There is a strong emphasis on companies leveraging technology and innovation to disrupt traditional markets, particularly in real estate and isotope production.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXX | X% | X | X% |
| YouTube | XXXXX | XX% | XXX | X% | X | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about RedChip in the last XX hours
Fathom Protocol (FTHM) Innovative Solutions & Support (ISSC) Gilead Sciences, Inc. (GILD) CoStar Group, Inc. (CSGP) Regeneron Pharmaceuticals Inc (REGN) Johnson & Johnson (JNJ) Artificial Intelligence (AI4) Rivian Automotive, Inc. (RIVN) Vistra, Corp. (VST) Constellation Energy Corp (CEG)
Top topics mentioned In the posts about RedChip in the last XX hours
nasdaq, investment, coins ai, coins real estate, stocks technology, acquisition, stocks, $fthm, asp, $110m, coins energy, amgn, $aspi, money, coins dao, $aent, $cldi, bold, $juns, $issc, new york stock exchange, $aents, coins entertainment, $gild, $trib, $bfrg, $fblg, networks, positions, world of, $csgp, $reax, $regn, ren, coins healthcare, $cadl, $jnj, artificial, $ai4, approved, robot, ip, disc, the worlds, cns, regulatory, ngc, drugs, multi, bloomberg, pioneer, superior, rivn, lev, $1211hk, byd, $rivn, $cbdw, vst, $vst, $ceg, $nne, $biaf, automation, pfe, manat, vrtx, $vrtx, $ilmn, $jseren, listing, south africa, longterm, $60m, nvda, abbv, $uis, wearables, $260b, vin, $bfrgs, sneak peek, pubg, nih, $176m, $pcsa, $ltrn, ai a, empower, capabilities, transformative, coins analytics, convergence, $apvos, mining, owned project, eco friendly, oral care, supplements, private equity
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"60 Degrees Pharma: Tackling Global Infectious Diseases with Cutting-Edge Therapies"
@redchip on YouTube 2025-07-25 17:36:41 UTC 33K followers, XX engagements
"🧬 FibroBiologics $FBLG Advancing Cell Therapy for Chronic Diseases @FibroBiologics is pioneering next-generation cell therapy using fibroblast cells to target some of the worlds most challenging chronic conditions: from multiple sclerosis and psoriasis to disc degeneration wound healing and even cancer. Why This Matters to Investors: Extensive IP Portfolio: 160+ U.S. and international patents and patents pending across diverse clinical pathways. Broad Pipeline Potential: Targeting high-need markets in orthopedics neurology oncology and regenerative medicine. Innovative Platform: Positioned"
@RedChip on X 2025-07-25 15:20:02 UTC 5594 followers, XX engagements
"✅ Regulatory Greenlight: @ASPIsotopes $ASPI Moves Closer to Strategic Acquisition of Renergen The Competition Commission of South Africa has approved ASP Isotopes offer to acquire @RenergenJHB marking a key milestone in a deal that could reshape the global supply of helium LNG and enriched isotopes. Why This Matters to Investors: - Helium + LNG Synergies: Renergen is backed by the U.S. government due to heliums strategic importance. The combined entity will build a vertically integrated supply chain across critical materials. - Revenue Accretion in 2026: $ASPI expects the transaction to be"
@RedChip on X 2025-07-25 14:10:36 UTC 5594 followers, XXX engagements
"🎥 Jupiter Neurosciences $JUNS: Watch the 30-Second Snapshot Investors Cant Miss $JUNS is redefining treatment for CNS disorders and rare diseases through its breakthrough resveratrol-based therapy JOTROL which delivers 9x greater bioavailability than traditional formulations. Backed by leading institutions like Harvard and $1.76M in NIH funding the company is advancing toward multiple Phase X trials in 2025. Why This Matters to Investors: Addressing $50B+ in combined market opportunities across Alzheimers Parkinsons and rare diseases. Clinical and commercial strategy: Prescription therapies"
@RedChip on X 2025-07-25 13:55:06 UTC 5594 followers, XX engagements